等待開盤 08-29 09:30:00 美东时间
-0.480
-1.97%
今日重点评级关注:Oppenheimer:维持Chemomab Therapeutics"跑赢大市"评级,目标价从10美元升至25美元;花旗:维持MongoDB"买入"评级,目标价从405美元升至425美元
08-28 09:51
Craig-Hallum analyst Chase Knickerbocker maintains Indivior (NASDAQ:INDV) with a Buy and raises the price target from $27 to $34.
08-28 01:54
Indivior (NASDAQ:INDV) announced on Tuesday that it is exploring strategic options for its nasal opioid overdose treatment, Opvee, as well as its international operations. In a recent filing, the comp...
08-26 21:30
Indivior ( ($INDV) ) just unveiled an update. Indivior PLC has launched the Ind...
08-26 20:17
Indivior ( ($INDV) ) just unveiled an announcement. On August 20, 2025, Indivio...
08-23 05:17
RICHMOND, Va., Aug. 20, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the following investor events: Morgan Stanley 23rd Annual Global Healthca...
08-21 00:00
U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on...
07-31 23:00
Indivior shares are trading higher after the company reported better-than-expec...
07-31 20:42
Indivior (NASDAQ:INDV) raises FY2025 sales outlook from $955.000 million-$1.025 billion to $1.030 billion-$1.080 billion vs $1.009 billion estimate.
07-31 19:03
Indivior (NASDAQ:INDV) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.25 by 104 percent. This is a 6.25 percent increase over earnings of $0.48 per share from the same
07-31 19:02